See more : Imperial Oil Limited (IMO) Income Statement Analysis – Financial Results
Complete financial analysis of Vivanza Biosciences Limited (VIVANZA.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vivanza Biosciences Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
You may be interested
- Turaco Gold Limited (TCG.AX) Income Statement Analysis – Financial Results
- Thorn Group Limited (TGA.AX) Income Statement Analysis – Financial Results
- MediaTek Inc. (2454.TW) Income Statement Analysis – Financial Results
- Software Effective Solutions Corp. (SFWJ) Income Statement Analysis – Financial Results
- Walliser Kantonalbank (WKBN.SW) Income Statement Analysis – Financial Results
Vivanza Biosciences Limited (VIVANZA.BO)
About Vivanza Biosciences Limited
Vivanza Biosciences Ltd. engages in the manufacture and trade of pharmaceutical products. Its product includes Intravenous (IV) Fusion. The company was founded on March 03, 1982 and is headquartered in Ahmedabad, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 278.89M | 178.07M | 104.00M | 98.88M | 96.21M | 26.59M | 64.40M | 34.75M | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 259.51M | 168.18M | 99.15M | 95.04M | 96.18M | 24.34M | 56.93M | 34.87M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 19.39M | 9.89M | 4.85M | 3.84M | 31.03K | 2.25M | 7.47M | -125.27K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 6.95% | 5.56% | 4.66% | 3.89% | 0.03% | 8.46% | 11.60% | -0.36% | 0.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.51M | 2.52M | 3.99M | 2.51M | 2.70M | 2.41M | 1.42M | 2.48M | 585.01K | 0.00 | 289.07K | 197.62K |
| Selling & Marketing | 42.00K | 79.00K | 33.00K | 32.78K | 31.18K | 26.73K | 21.09K | 87.64K | 22.75K | 60.80K | 0.00 | 0.00 |
| SG&A | 4.56M | 2.60M | 4.02M | 2.54M | 2.73M | 2.44M | 1.45M | 2.57M | 607.76K | 60.80K | 289.07K | 197.62K |
| Other Expenses | 0.00 | -368.00K | -204.00K | -314.87K | -635.62K | -12.75K | -2.76K | -328.81K | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 4.56M | 2.97M | 4.22M | 2.86M | 3.37M | 2.45M | 1.45M | 2.90M | 607.76K | 525.87K | 534.68K | 15.99M |
| Cost & Expenses | 264.06M | 171.15M | 103.37M | 97.90M | 99.55M | 26.79M | 58.38M | 37.77M | 607.76K | 525.87K | 534.68K | 15.99M |
| Interest Income | 4.13M | 0.00 | 0.00 | 4.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 42.00 | 0.00 | 4.09K |
| Interest Expense | 0.00 | 4.25M | 4.32M | 4.74M | 4.42M | 4.21M | 3.70M | 434.37K | 563.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 121.00K | 26.00K | 74.00K | 98.43K | -244.08K | 224.27K | -5.89M | 2.79M | 602.76K | 525.36K | 509.35K | 537.68K |
| EBITDA | 11.20M | 11.38M | 8.57M | 2.88M | 2.37M | -198.55K | 143.05K | 108.48K | 0.00 | 1.00 | -25.00K | -15.99M |
| EBITDA Ratio | 4.02% | 3.90% | 0.68% | 1.09% | -3.47% | -0.75% | 9.35% | -8.71% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Income | 14.83M | 6.92M | 629.00K | 983.90K | -3.34M | -198.55K | 6.02M | -3.03M | -607.76K | -525.36K | -509.35K | -537.68K |
| Operating Income Ratio | 5.32% | 3.89% | 0.60% | 1.00% | -3.47% | -0.75% | 9.35% | -8.71% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -7.88M | 243.00K | 2.71M | -3.16M | 1.28M | -4.21M | -3.69M | -88.17K | 4.44K | -547.00 | -25.34K | -5.44M |
| Income Before Tax | 6.95M | 7.17M | 3.33M | 1.23M | -2.06M | -4.41M | 2.34M | -3.11M | -603.32K | -525.91K | -534.68K | -15.99M |
| Income Before Tax Ratio | 2.49% | 4.02% | 3.21% | 1.25% | -2.14% | -16.58% | 3.63% | -8.96% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 1.48M | 1.18M | 4.00K | 481.51K | 244.08K | -161.14K | 281.48K | -2.79M | -602.76K | -547.00 | -25.34K | -15.45M |
| Net Income | 5.47M | 5.98M | 3.33M | 753.35K | -2.06M | -4.41M | 2.05M | -3.11M | -603.32K | -525.91K | -534.68K | -15.99M |
| Net Income Ratio | 1.96% | 3.36% | 3.20% | 0.76% | -2.14% | -16.58% | 3.19% | -8.96% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | 0.14 | 0.15 | 0.08 | 0.02 | -0.05 | -0.11 | 0.05 | -0.10 | -0.10 | -0.28 | -0.28 | -8.51 |
| EPS Diluted | 0.14 | 0.15 | 0.08 | 0.02 | -0.05 | -0.11 | 0.05 | -0.10 | -0.10 | -0.28 | -0.28 | -8.51 |
| Weighted Avg Shares Out | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 31.85M | 6.27M | 1.88M | 1.88M | 1.88M |
| Weighted Avg Shares Out (Dil) | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 40.00M | 31.85M | 6.27M | 1.88M | 1.88M | 1.88M |
No news found for: VIVANZA.BO
Source: https://incomestatements.info
Category: Stock Reports